Drug Profile
Morinidazole - Jiangsu Hansoh Pharmaceutical
Alternative Names: MailingdaLatest Information Update: 23 Mar 2020
Price :
$50
*
At a glance
- Originator Jiangsu Hansoh Pharmaceutical
- Class Alcohols; Anti-infectives; Morpholines; Nitroimidazoles
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bacterial infections
Most Recent Events
- 04 Aug 2017 Zhejiang University and Shanghai Hansoh Biomedical plan a phase I trial in Healthy volunteers in (ChiCTR-IIR-17012161)
- 31 Dec 2014 Launched for Bacterial infections in China (IV) (Jiangsu Hansoh Pharmaceutical website, March 2020)